Concepedia

Author

Alison H. Thomson

University of StrathclydeORCID

Also Known As

A H Thomson, A Thomson, A. H. Thomson, A. Thomson, A.H Thomson, A.H. Thomson, Alison H Thomson, Alison H. Thomson, Alison Thomson, Thomson, Alison

109

Publications

3.4K

Citations

32

H-Index

80

Concepts

All Affiliations

University of StrathclydeWestern InfirmaryUniversity of GlasgowNHS Greater Glasgow and ClydeStobhill Hospital
AH

About

Alison H. Thomson is an author at University of Strathclyde specializing in medicine, pharmacology, and pharmacokinetics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

18

1.3K

2

Public Health

2

2

105

3

Education

1

1

11

4

Engineering

1

1

16

5

Health Sciences

1

1

45

Alison H. Thomson

×

52

Publications

3K

Citations

29

H-Index

YearCitations

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.

P. Vasey, Stan B. Kaye, Rachel Morrison,

PubMed

1999

691

Cost-Effectiveness of Therapeutic Drug Monitoring

Daan J. Touw, Cees Neef, Alison H. Thomson,

Therapeutic Drug Monitoring

2005

205

Increase in emergency admissions to hospital for children aged under 15 in England, 1999-2010: national database analysis

P. J. Gill, Michael J Goldacre, David Mant,

Archives of Disease in Childhood

2013

184

Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations

Alison H. Thomson, Christine E. Staatz, C. M. Tobin,

Journal of Antimicrobial Chemotherapy

2009

140

External evaluation of population pharmacokinetic models of vancomycin in neonates: the transferability of published models to different clinical settings

Wei Zhao, Florentia Kaguelidou, Valérie Biran,

British Journal of Clinical Pharmacology

2012

112

Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration

Lucy J Giles, Anne Jennings, Alison H. Thomson,

Critical Care Medicine

2000

110

Predictors of new onset diabetes after renal transplantation

Nicola Joss, Christine E. Staatz, Alison H. Thomson,

Clinical Transplantation

2007

99

Vancomycin Pharmacokinetics Throughout Life: Results from a Pooled Population Analysis and Evaluation of Current Dosing Recommendations

Pieter Colin, Karel Allegaert, Alison H. Thomson,

Clinical Pharmacokinetics

2019

87

Population pharmacokinetics in phase I drug development: a phase I study of PK1 in patients with solid tumours

Alison H. Thomson, P. Vasey, Lilian S. Murray,

British Journal of Cancer

1999

81

Models for time‐varying covariates in population pharmacokinetic‐pharmacodynamic analysis

Ulrika Wählby, Alison H. Thomson, Peter A. Milligan,

British Journal of Clinical Pharmacology

2004

69

Page 1